A randomized phase II trial of veliparib (V), radiotherapy (RT) and temozolomide (TMZ) in patients (PTS) with unmethylated MGMT (uMGMT) glioblastoma (GBM): The vertu study

Khasraw, Mustafa; McDonald, Kerrie Leanne; Rosenthal, Mark; Lwin, Zarnie; Ashley, David; Wheeler, Helen; Barnes, Elizabeth; Foote, Matthew; Koh, Eng-Siew; Sulman, Erik; Back, Michael; Buckland, Michael; Sim, Hao-Wen; Fisher, Lauren; Leonard, Robyn; Hall, Merryn; Yip, Sonia; Simes, John

A randomized phase II trial of veliparib (V), radiotherapy (RT) and temozolomide (TMZ) in patients (PTS) with unmethylated MGMT (uMGMT) glioblastoma (GBM): The vertu study

journal contribution

posted on 2019-11-01, 00:00 authored by Mustafa Khasraw, Kerrie Leanne McDonald, Mark Rosenthal, Zarnie Lwin, David Ashley, Helen Wheeler, Elizabeth Barnes, Matthew Foote, Eng-Siew Koh, Erik Sulman, Michael Back, Michael Buckland, Hao-Wen Sim, Lauren Fisher, Robyn Leonard, Merryn Hall, Sonia Yip, John Simes

A randomized phase II trial of veliparib (V), radiotherapy (RT) and temozolomide (TMZ) in patients (PTS) with unmethylated MGMT (uMGMT) glioblastoma (GBM): The vertu study

History

Related Materials

1.
DOI - Is version of https://doi.org/10.1093/neuonc/noz175.067

Location

Oxford, Eng.

Open access

Yes

Link to full text

https://academic.oup.com/neuro-oncology/article-pdf/21/Supplement_6/vi18/30632775/noz175.067.pdf

Language

eng

Author URL

http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000509478700068&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a045e4b2bb1f2b747c68c720ec8913b7

Notes

Abstract from the 24th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology November 22 – 24, 2019 Phoenix, Arizona

Publication classification

E3 Extract of paper

Journal

Neuro-Oncology

Volume

21

Season

Supplement 6

Pagination

18-18

Start date

2019-11-20

End date

2019-11-24

ISSN

1522-8517

eISSN

1523-5866

Publisher

Oxford University Press

Usage metrics

Keywords

Clinical Neurology Life Sciences & Biomedicine Neurosciences & Neurology Oncology Science & Technology 3211 Oncology and carcinogenesis

A randomized phase II trial of veliparib (V), radiotherapy (RT) and temozolomide (TMZ) in patients (PTS) with unmethylated MGMT (uMGMT) glioblastoma (GBM): The vertu study

History

Related Materials

Location

Open access

Link to full text

Language

Author URL

Notes

Publication classification

Journal

Volume

Season

Pagination

Start date

End date

ISSN

eISSN

Publisher

Usage metrics

Categories

Keywords

Licence

Exports